Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

The Synthetic Human Genome Project (SynHG) will take decades to complete and cost anything from millions to hundreds of ...

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

In April, the U.S. Food and Drug Administration (FDA) approved the commercial distribution of pigs genetically edited with ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

The Synthetic Human Genome, or Syn HG, a project launched on June 26th, aims to change that. Funded partly by Wellcome, a ...

MIT engineers have developed a new kind of low-cost, easy-to-use sensor that could bring fast and affordable disease testing ...

A newer technology called genome editing or gene editing has emerged in the last decade. “Gene editing is basically just conventional breeding, but done more intelligently,” she summarizes. “This ...

MIT’s CRISPR sensor detects cancer and HIV for 50 cents and stays effective for two months without refrigeration.

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such ...